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ABSTRACT
A GUIDE TO PHARMACOLOGY FOR AUDIOLOGISTS
by
LAUREN E PASKO

Advisors: Brett A. Martin, Ph.D. and Carol A. Silverman, Ph.D.
Objective: The purpose of this research is to develop a pharmacology guide for Audiologists and
Audiology students to promote patient-centered care in audiology.
Introduction: Clinical audiology doctoral (Au.D.) graduate programs provide little education to
audiology students on the topic of pharmacology. In order to provide optimal, patient-centered
care, the Audiologist must be familiar with commonly prescribed medications, the conditions
that they are used to treat, and their effects on the body. Knowledge of patient medication use
can help the Audiologist orient their practice to the present health condition of the patient. An
evidence-based guide for audiologists and audiology students on the 25 most commonly
prescribed medications in the United States is presented. This guide was developed to enhance
patient-centered clinical practice for Audiologists and Audiology students using knowledge of
common medications and the implications of medication use.
Methods: Using a list from the ClinCalc online Drugstats database, the 25 most commonly
prescribed medications in the United States in 2019 were gathered. A chart was compiled using
information from PDR.net: Providers Digital Reference to include rank of prescription, drug
generic name, drug class(es), description of drug, mechanism of action, treatment uses, off-label
uses, and drug adverse reactions including: vestibular side effects, tinnitus side effects, ear side
effects, cognitive side effects, visual side effects and other audiologically-relevant side effects.
Results: The guide is compiled and included as a link in table format. Additional tables are
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included to show frequency of drug class, generic name and treatment uses, frequency of
vestibular side effects, frequency of tinnitus side effects and frequency of ear side effects.
Dissemination: This chart is to be presented in fulfillment of the Doctor of Audiology capstone
project at the CUNY Graduate Center. A digital copy will be provided to all faculty and student
attendees of the capstone presentation and can henceforth be used at student clinical sites.
Discussion: After dissemination, this chart is intended for clinical use by faculty and students to
aid in clinical decision-making and promote patient-centered clinical care.

Key Words: “audiology,” “pharmacology,” “medication,” “medicine,” “patient-centered”
“patient-centered care,” “side effects,” “ototoxicity,” “cognition,” “vision,” “tinnitus,” “vertigo,”
“hearing loss,” “prescriptions” “dizziness.”
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INTRODUCTION
Certification Requirements for Audiologists
The American Speech Language Hearing Association (ASHA) defines an Audiologist as
an expert in providing services in the prevention, diagnosis and evidence-based treatment of
hearing and balance disorders for people of all ages (American Speech-Language-Hearing
Association, n.d.). Audiologists provide services which minimize the negative impact of hearing
and balance disorders and work towards improving outcomes and quality of life for their
patients. Audiologists must be skilled in identification, assessment, management, treatment,
prevention and education of hearing and balance disorders as they relate to professional work
(American Speech-Language-Hearing Association, n.d.).
In order to determine the present level of education on pharmacology in audiology for
graduate students, a recently published introductory clinical audiology book was searched for the
key words, “medication” and “drug.” The book is titled “Clinical Audiology an Introduction,”
and was published in 2021 (Stach & Ramachandran, 2021). The word “medication” appeared in
the text ten times. Four of the ten appearances are in reference to ototoxic medications and the
mechanism by which they affect the ears and hearing. Three of the appearances are in reference
to medical treatment of hearing loss, including treatment of otitis media. The word “medication”
was used two times to refer to the effects of drugs on the vestibular system, and it was used one
time in reference to a list of case history questions (Stach & Ramachandran, 2021).
The word “drug,” was used thirty-six times throughout the duration of the text (Stach &
Ramachandran, 2021). Most of the references were in explanation of ototoxicity and the effects
of chemotherapy on the cochlea. Additionally, there were references to the Food and Drug
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Administration, drugs as a treatment for ear disease or hearing loss and drug use during
pregnancy and its effects on fetal and infant development (Stach & Ramachandran, 2021).
Audiologists are credentialed by the Council for Clinical Certification in Audiology and
Speech-Language Pathology (CCFC), which has the responsibility of defining the standards for
clinical certification and applying those standards in granting certification to applicants (Clinical
Certification in Audiology and Speech-Language Pathology of the American Speech-LanguageHearing Association, 2018). In order to obtain a Certificate of Clinical Competence in Audiology
(CCC-A), an applicant must meet the five standards defined by the CCFC which went into effect
on January 1, 2020 (Clinical Certification in Audiology and Speech-Language Pathology of the
American Speech-Language-Hearing Association, 2018). Standard I, Academic Qualifications,
states that applicants must submit verification of a doctoral degree from a program which is
accredited by the Council on Academic Accreditation (CAA) (Clinical Certification in
Audiology and Speech-Language Pathology of the American Speech-Language-Hearing
Association, 2018). Standard II, Knowledge and Skills Outcomes, requires the applicant to have
acquired knowledge and skills in specified areas of practice (Clinical Certification in Audiology
and Speech-Language Pathology of the American Speech-Language-Hearing Association, 2018).
There are six areas of practice identified which include: Foundations of Practice, Prevention and
Screening, Audiologic Evaluation, Counseling, Audiologic Rehabilitation Across the Lifespan,
and Pediatric Audiologic (Re)habilitation (Clinical Certification in Audiology and SpeechLanguage Pathology of the American Speech-Language-Hearing Association, 2018). Of these
standards, the following are identified as related to the knowledge of pharmacology:
A2. Effects of pathogens, and pharmacologic and teratogenic agents, on the auditory and
vestibular systems
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A7. Applications and limitations of specific audiologic assessments and interventions in
the context of overall client/patient management
A9. Implications of biopsychosocial factors in the experience of and adjustment to
auditory disorders and other chronic health conditions
B1. Educating the public and those at risk on prevention, potential causes, effects, and
treatment of congenital and acquired auditory and vestibular disorders
B3. Participating in programs designed to reduce the effects of noise exposure and agents
that are toxic to the auditory and vestibular systems
C1. Gathering, reviewing, and evaluating information from referral sources to facilitate
assessment, planning, and identification of potential etiologic factors
C2. Obtaining a case history and client/patient narrative
D1. Identifying the counseling needs of individuals with hearing impairment based on
their narratives and results of client/patient and/or caregiver responses to questionnaires
and validation measures
D2. Providing individual, family, and group counseling as needed based on client/patient
and clinical population needs
E2. Identifying the need for, and providing for assessment of, concomitant
cognitive/developmental concerns, sensory-perceptual and motor skills, and other
health/medical conditions, as well as participating in interprofessional collaboration to
provide comprehensive management and monitoring of all relevant issues
E7. Developing and implementing individualized intervention plans based on
clients’/patients’ preferences, abilities, communication needs and problems, and related
adjustment difficulties
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E22. Counseling clients/patients regarding the audiologic significance of tinnitus and
factors that cause or exacerbate tinnitus to resolve misconceptions and alleviate anxiety
related to this auditory disorder (Clinical Certification in Audiology and SpeechLanguage Pathology of the American Speech-Language-Hearing Association, 2018).
Standard III, Verification of Knowledge and Skills, states that the applicant must have
completed supervised clinical practicum under an experienced ASHA certified Audiologist
(Clinical Certification in Audiology and Speech-Language Pathology of the American SpeechLanguage-Hearing Association, 2018). Standard IV, Examination, states that the applicant must
pass the national Praxis examination, and Standard V, Maintenance of Certification, states that
those who hold certification must demonstrate continuing professional development, adherence
to the ASHA code of ethics and maintain payment of annual dues and fees (Clinical Certification
in Audiology and Speech-Language Pathology of the American Speech-Language-Hearing
Association, 2018). Certification in audiology requires the certification applicant to have a
general understanding of drugs and their effects on the patient.
The study of basic pharmacology is necessary for the audiologist. As per standard A2,
audiologists must know the effects of pathogens, and pharmacologic and teratogenic agents, on
the auditory and vestibular systems (Clinical Certification in Audiology and Speech-Language
Pathology of the American Speech-Language-Hearing Association, 2018). In partial fulfilment
of this requirement, audiologists must be familiar with commonly prescribed medications which
have potential effects on the auditory and vestibular systems. Prescription medications may have
main effects or side effects that cause changes in the patient’s auditory or vestibular system. To
practice well and ethically, the audiologist must be aware of these potential changes.
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Standard A7 requires that the audiologist understands applications and limitations of
specific audiological assessments and interventions in the context of overall client/patient
management (Clinical Certification in Audiology and Speech-Language Pathology of the
American Speech-Language-Hearing Association, 2018). Knowledge of commonly used
medications can aid the audiologist in understanding certain limitations of audiologic testing. For
example, certain medications will render videonystagmography (VNG) results invalid, and other
medications may cause a temporary threshold shift, which would affect comprehensive
audiological evaluation (CAE) results.
In order for the audiologist to fulfil standard A9, which requires the understanding of the
implications of biopsychosocial factors in the experience of and adjustment to auditory disorders
and other chronic health conditions, knowledge of common medications may be useful (Clinical
Certification in Audiology and Speech-Language Pathology of the American Speech-LanguageHearing Association, 2018). Patient prescription drug use can have an effect on the
biopsychosocial factors which are involved in adjustment to auditory disorders and other hearing
conditions. In addition, knowledge of the conditions which common medications are used to
treat can be indicative to the audiologist of a patient’s chronic health conditions.
Standard B1 outlines the responsibility of the audiologist to educate the public on
prevention, potential causes, effects and treatment of auditory and vestibular disorders (Clinical
Certification in Audiology and Speech-Language Pathology of the American Speech-LanguageHearing Association, 2018). Basic knowledge of prescription medications and their effects on the
auditory and vestibular systems is necessary for the audiologist to be able to educate properly in
these areas. Many common medications can cause dizziness, hearing loss, tinnitus and other
effects, and it is the role of the audiologist to promote awareness of these side effects.
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Standard B3 requires the audiologist to participate in programs which are designed to
reduce the effects of noise exposure and toxic agents (Clinical Certification in Audiology and
Speech-Language Pathology of the American Speech-Language-Hearing Association, 2018). In
order to participate in such programs, the audiologist must have knowledge of ototoxic
medications and their uses. It is important for the audiologist to be able to advocate for the
proper course of treatment for a patient who is being treated with a drug that is toxic to the
vestibular or auditory system.
Standard C1 states that the audiologist must have skills in evaluating information from
referral sources with the goal of enhancing patient care (Clinical Certification in Audiology and
Speech-Language Pathology of the American Speech-Language-Hearing Association, 2018). In
order to do this properly, the audiologist should be able to identify medications highlighted by
referral sources and use the information to facilitate the plan of diagnosis and treatment of the
patient. If the referring provider presents information about the patient which includes their
present medications, the audiologist should be able to use this information to guide their decision
making throughout their appointments with that patient.
As outlined in standard C2, the audiologist should have knowledge and skills in obtaining
a case history of their patient (Clinical Certification in Audiology and Speech-Language
Pathology of the American Speech-Language-Hearing Association, 2018). It is important that a
clinical intake for audiology includes a question regarding current medication use. It is even
more important that the audiologist knows how to interpret the information given by the patient
in response to this question. Use of medication by a patient can have an effect on audiological
testing, test results and ability to participate in certain treatment plans. In addition, the results of
the audiological evaluation performed by the audiologist, in context with the medications
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prescribed, can inform the referring physician and can be used to modify the treatment plan as
well as the medications prescribed to the patient.
Standard D1 states that the audiologist must use the narrative presented by the patient to
inform their counseling techniques and goals (Clinical Certification in Audiology and SpeechLanguage Pathology of the American Speech-Language-Hearing Association, 2018). The patient
narrative may include medication history, which can inform patient-centered counseling and
treatment goals. An example of this would be an audiologist who adapts a patient’s hearing aid
style after hearing in their patient narrative that the patient is on medication which produces
tremors as a side effect. If a clinical setting has an intake form which asks for patient medical
conditions and medication usage, the audiologist should be able to use this information to guide,
but not determine, their clinical techniques.
According to standard D2, the audiologist must provide counseling as needed based on
patient and clinical population needs (Clinical Certification in Audiology and Speech-Language
Pathology of the American Speech-Language-Hearing Association, 2018). The knowledge of
common medications would inform the audiologist how to counsel individuals based on clinical
need. For example, an audiologist might see that a patient is taking medication that is used to
treat Attention Deficit Hyperactivity Disorder (ADHD) and adapt their counseling strategy and
treatment plan with the knowledge that the patient may have trouble with executive functioning
and focusing.
Standard E2 outlines the need for the audiologist to be aware of coexisting health and
medical conditions which may require interprofessional collaboration in order to properly treat
all of the patient’s relevant issues (Clinical Certification in Audiology and Speech-Language
Pathology of the American Speech-Language-Hearing Association, 2018). It is important for
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audiologists to be knowledgeable about common medications and the conditions that they are
used to treat when working with other professionals. It can be assumed that most other healthcare
professionals have some to vast knowledge of pharmacology, and audiologists need to be able to
understand the implications of medications in order to effectively work inter-professionally with
others.
Similar to Standard D2, Standard E7 requires that the audiologist develop individualized
plans of care which account for a patient's abilities and related adjustment difficulties (Clinical
Certification in Audiology and Speech-Language Pathology of the American Speech-LanguageHearing Association, 2018). Existing knowledge of a patient's medications and greater medical
history makes it possible for the audiologist to further individualize the intervention and plan of
care to suit the needs of the patient. For example, a case history which includes medications may
prompt the audiologist to change aspects of a patient’s hearing aid fitting, if a medication
indicates that the patient may have limited ability.
Lastly, Standard E22 states that the audiologist must be prepared to explain tinnitus and
it’s causes to patients who experience tinnitus-related anxiety (Clinical Certification in
Audiology and Speech-Language Pathology of the American Speech-Language-Hearing
Association, 2018). Tinnitus is a common side effect of many different commonly prescribed
medications. Knowledge of what medications could potentially cause tinnitus would better equip
the audiologist to counsel a tinnitus patient on possible sources of their tinnitus.
Basic Overview of Pharmacology for the Audiologist
The Audiologist is a health professional and ethical practice requires basic knowledge of
commonly prescribed medications, the conditions they are used to treat, and their side effects.
There are over 2,000 drugs which have side effects that could result in misdiagnosis of a hearing
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or vestibular problem (DiSogra, 2019). Offerdahl and Mishra introduce the and explain common
terminology in the field of pharmacology as well as some of the basic principles of the discipline
(Offerdahl & Mishra, 2019). They justify their review by saying that that as a part of the
healthcare team, the audiologist should be able to be able to explain audiologic manifestations of
the chemicals found in drugs to other healthcare professionals (Offerdahl & Mishra, 2019). In
every patient interaction, it is necessary to evaluate the patient from the pharmaceutical
perspective, as to produce the best possible outcomes and minimize otologic harm (Cianfrone et.
al, 2011). In addition, it is of significant importance that the audiologist prevents an ototoxic
effect in a patient as often as possible (Offerdahl & Mishra, 2019).
Pharmacology is generally defined as the study of any substance that affects or interacts
with any living organism through a chemical process, which typically causes an activation or
inhibition of natural body processes (Katzung & Trevor, 2012). Pharmacology is closely related
to toxicology, which is the branch of pharmacology with the harmful effects of chemical
substances on living organisms (Katzung & Trevor, 2012). Pharmacology and toxicology must
be considered together to find a balance between benefit and harm. Many chemicals that are used
for their therapeutic effects on the organism also have co-occurring undesirable effects on the
organism (Katzung & Trevor, 2012). Mediating the desirable and undesirable effects of
medications on the body is an important part of medicine, pharmacy and research (Katzung &
Trevor, 2012). In the present review, the words drug, prescription, medicine and medication will
be used to refer to chemical substances which interact with living organisms.
Offerdahl and Mishra (2019) explain that pharmacology is inseparable from the study of
chemistry, however, it is not necessary for an audiologist to have an extensive knowledge of
chemistry to effectively use pharmacology to enhance patient interactions (Offerdahl & Mishra,
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2019). Only a basic knowledge is required for the audiologist to have effective communication
on the topic of pharmacology with a patient. There are two subclasses of pharmacology:
pharmacokinetics and pharmacodynamics. The four steps of pharmacokinetics include
absorption, distribution, metabolism and elimination (Offerdahl & Mishra, 2019).
These four steps outline the process of a medication’s time and travel through the body.
Absorption refers to the process by which the drug enters and is spread throughout the body,
including dosage and type of drug administration (Offerdahl & Mishra, 2019). This is the first
step in the process. After absorption, distribution outlines the movement of chemicals into areas
outside of the blood stream. An important reference for distribution is the concentration of the
drug inside the body compartment, namely, the volume of distribution (Offerdahl & Mishra,
2019). Distribution refers to all parts of the body, not just the areas where therapeutic effect is
intended (Offerdahl & Mishra, 2019). This is an important concept for the audiologist, as drugs
are typically distributed to the entire body, whether a therapeutic effect is intended for the area.
An example of this would be an ototoxic chemotherapy drug. Its intended purpose of cancer
treatment may come at the unintended cost of the health of the inner ear.
Negative side effects are produced when a drug has unintended consequences on a part of
the body outside of the intended area of effect (Offerdahl & Mishra, 2019). Drug metabolism
refers to the termination of drug activity, including the process of making a drug more water
soluble for elimination by way of the kidneys (Offerdahl & Mishra, 2019). The final step in the
process is elimination, which is the process by which the drug leaves the body through urine. In
contrast to pharmacokinetics, pharmacodynamics refers to the mechanism of action that produces
the therapeutic effects and the toxic effects of the chemical on the body (Offerdahl & Mishra,
2019). Pharmacodynamics is an explanation of what exactly the drug does to the body (Offerdahl
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& Mishra, 2019). As per the review of a recent graduate level audiology text, there is limited
information presented to audiologists at the graduate education level regarding pharmacology
and the mechanism of action by which drugs are processed in the body (Stach & Ramachandran,
2021). Audiology students may benefit from a brief introduction to pharmacokinetics and
pharmacodynamics as to enhance knowledge on medications and their possible effects on the
body as well as effects on audiological practice.
Justification for Guide Categories
In the present study, it is proposed to present a list of the top 25 most commonly
prescribed medications in the United States in 2019 in a guide listed with possible effects of
these medications on audiological practice. In 2011, Cianfrone et al. (2011) created a guide to
outline drug induced ototoxicity, tinnitus and vertigo with the intention of aiding physicians in
the evaluation of evaluating the risks and benefits of prescription medications as related to the
ear (Cianfrone et al., 2011). It is the job of the physician or medical professional, as opposed to
the audiologist, to work towards a balance of effectiveness and safety when prescribing drugs to
patients (Cianfrone et al., 2011). However, audiologists do still have the indirect responsibility to
optimize patient care and interactions involving pharmacology (Cianfrone et al., 2011). In their
article, Cianfrone et al. (2011) highlight three main adverse side effects which include:
ototoxicity (general), tinnitus and vertigo (Cianfrone et al., 2011).
Ototoxicity is the toxic capacity of chemicals on the cochlea and inner ear structures
(Cianfrone et al., 2011). Ototoxic damage can manifest as symptoms of hearing loss, tinnitus,
vertigo, hyperacusis and deafness (Cianfrone et al., 2011). All of the above are important
medical conditions of the inner ear which can be caused by drug use. These symptoms can occur
together or individually, rapidly or over time, and they can be permanent or reversible (Cianfrone
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et al., 2011). The guide by Cianfrone et al. (2011) uses four categories to classify drug safety.
The first category is ototoxicity, generally, including hearing damage, vertigo and tinnitus
(Cianfrone et al., 2011). The second category is the onset of tinnitus only with no hearing
impairment, and the third category is the onset of vertigo only with no noted hearing loss
(Cianfrone et al., 2011). The final category includes drugs with possible audiologic effects
(Cianfrone et al., 2011). The guide created by Cianfrone et. al. (2011) is an extensive, although
now outdated, categorization of many drugs and the risk of ototoxic effects on the ear including
tinnitus and vertigo. In the present review, the medications are categorized by their effects on the
ear, including tinnitus, general ear effects and vestibular effects, as was done in this article,
however, categories were added to determine the effects of drugs on cognition, vision and other
audiologically relevant side effects. These categories were added to extend the application of the
guide to medications which are used more commonly but have broader effects on the body
outside of direct ear effects.
While knowledge of medication side effects directly related to otologic health and
function are very important for clinical audiology practice, there are additional factors which can
influence testing and treatment of patients by an audiologist. Additional information included in
this review are treatment uses (including off-label), cognitive side effects including: amnesia,
confusion, memory impairment, depression, anxiety, hallucinations, irritability, impaired
cognition, psychosis, hostility, suicidal ideation and mania, visual side effects including: blurred
vision, photosensitivity, visual impairment, diplopia, optic neuritis, optic atrophy, amblyopia,
xanthopsia and myopia and other side effects deemed relevant to audiology and audiologic
testing.
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Cognition, and disorders of the cognitive system can have various effects on audiological
testing and diagnosis of hearing loss and balance disorders. Beck and Harvey (2021) summarize
the important relationships between cognition, amplification and audition (Beck & Harvey
2021). Hearing and cognition are correlated, particularly in older adult populations. There are a
few hypotheses which may explain the relationship, including the common cause hypothesis,
which posits that hearing loss and cognitive decline share the same cause (Beck et. al., 2020). In
addition, the social effects hypothesis states that hearing loss may lead to social disengagement
which may lead to accelerated cognitive decline (Beck et. al., 2020). The auditory deprivation
hypothesis notes that lack of auditory input results in neuroplastic changes due to lack of cortical
input. Lastly, the cognitive load hypothesis posits that hearing loss discourages typical
functioning of the temporal lobe which may cause the diversion of cognitive resources from
memory to auditory processing (Beck et. al., 2020). If any of the latter three hypotheses are true,
it is relevant for audiologists to know any cognitive side effects resulting from prescription
medication use.
There are many factors that contribute to a patient’s ability to complete audiological
testing, treatment and rehabilitation. Saunders (2015) notes that many non-auditory factors
influence hearing aid outcomes such as cognition, memory, dexterity, tactile sensitivity, health
literacy and vision (Saunders, 2015). This is particularly relevant to older adult patients as they
are more likely to experience those factors, and subsequent difficulty with hearing aid uptake.
Saunders conducted a study among older veterans to determine the effects of non-auditory
factors on hearing aid outcomes (Saunders, 2015). The audiologist can use information regarding
patient medication use to direct their counseling sessions and to promote patient-centered care.
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The results of the study beget suggestions to the audiologist for best hearing aid practice
for patients with these issues. The suggestions by Saunders (2015) include the following: 1) Take
home materials can help patients with memory issues. 2) Counseling information should be
given with the literacy level and targeted to the needs of the patient. 3) Place an emphasis on the
need for strong lighting while working with hearing aids. 4) Counsel patients on the importance
of patience when handling their hearing aids, especially if they have poor tactile sensitivity or
manual dexterity (Saunders, 2015). Many medications cause cognitive, visual and other side
effects which may have an effect on a patient’s ability to have an audiological test and/or ability
to follow through on audiologist’s recommendations, particularly regarding use of amplification.
In addition, the audiologist will benefit from knowing the conditions that a patient’s medication
is used to treat. For example, if a patient only shares their medication list, but does not disclose
specific medical conditions, the audiologists can make educated assumptions. If a patient is
taking multiple medications used to treat Parkinson’s disease, the audiologist may decide to
choose a hearing aid for the patient that is easier to manipulate, due to the potential issues with
manual dexterity that are associated with the disease.
Aims of the Present Study
ASHA standards require a basic knowledge of pharmacology in order for an audiologist
to practice at the level of clinical competence (Clinical Certification in Audiology and SpeechLanguage Pathology of the American Speech-Language-Hearing Association, 2018). Presently,
Audiology Doctorate programs provide little education regarding medication effects on the
practice of audiology, outside of descriptions of ototoxicity and medical treatment of hearing loss
(Stach & Ramachandran, 2021). Audiologists and audiology students would benefit from further
knowledge on prescription drugs and the main and side effects of those drugs as it relates to
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patient care in audiology. The guide presented in the current research is based off a previous
study by Cianfrone et. al. (2011). This guide of the top 25 most commonly prescribed
medications in the United States in 2019 is presented with the goal that it can be used to enhance
audiological practice and patient centered care in clinical settings.
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METHODS
For this review, the list of the top 25 most commonly prescribed drugs in the United
States in 2019 was drawn from the ClinCalc Drugstats review and assembled into an excel chart
which is referred to as the guide (Kane, 2020). This is the provided link to the database:
https://clincalc.com/DrugStats/Top200Drugs.aspx . The first column of the guide lists the rank of
prescription according to the ClinCalc review (Kane, 2020). The 25 most commonly prescribed
medications in the United States as per ClinCalc are listed in column two (Kane, 2020).
Additionally, the estimated total number of prescriptions and estimated total number of patients
taking the medication in 2019 were drawn from the ClinCalc Drugstats review and are listed in
column 3 and 4 of the guide, respectively. (Kane, 2020). Column 5 lists the brand names which
are used to identify the generic drug as per PDR.net (PDR Search, n.d). Column 6 includes the
drug class(es) of each medication (PDR Search, n.d). Column 7 contains a brief description of
each medication which is directly quoted from the PDR.net site (PDR Search, n.d). This is the
provided link to the database: https://www.pdr.net/. The mechanism of action for each drug is
directly quoted from PDR.net in column 8, included to give the reader the exact pharmacokinetic
and pharmacodynamic movements within the body (PDR Search, n.d).
Column 9 lists the identified treatment uses for the listed medications and column 10 lists
any known off-label uses if there are any (PDR Search, n.d). Columns 11-16 list the noted
adverse reactions of each drug, the time of onset and the incidence of reaction (PDR Search, n.d).
Column 11 lists vestibular side effects including: dizziness, syncope, vertigo, orthostatic
hypotension and nystagmus (PDR Search, n.d). Column 12 notes whether a drug has a tinnitus
adverse effect (PDR Search, n.d). Column 13 lists ear effects including hearing loss and otalgia
(PDR Search, n.d). Cognitive side effects, namely amnesia, confusion, memory impairment,
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depression, anxiety, hallucinations, irritability, impaired cognition, psychosis, hostility, suicidal
ideation and mania are included in column 14 (PDR Search, n.d). In column 15, visual effects
including blurred vision, photosensitivity, visual impairment, diplopia, optic neuritis, optic
atrophy, amblyopia, xanthopsia and myopia are listed (PDR Search, n.d). Column 16 outlines
additional relevant side effects that cannot be further categorized for the purposes of this review,
for example: tremors, peripheral neuropathy, and fatigue (PDR Search, n.d).
The full guide is linked in the results section of this paper. After the completion of the
guide, the results were further organized into smaller lists and tables to provide more specific
results. They are listed in the results section and in tables 1-6.
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RESULTS
The link to the full guide is provided here: Guide to Pharmacology for Audiologists.
For clarity, the prescription rank as well as the generic name of the top 25 medications is
listed in order of use in Table 1 using information gathered on the ClinCalc Database (Kane,
2020). The most commonly prescribed medication is Atorvastatin followed by Levothyroxine
and Lisinopril (Kane, 2020).
Table 1. Top 25 Most Commonly Used Medications as per ClinCal Database by Rank.
Prescription
Rank
1

Generic Name of Prescription

2

Levothyroxine

3

Lisinopril

4

Metformin

5

Metoprolol

6

Amlodipine

7

Albuterol

8

Omeprazole

9

Losartan

10

Gabapentin

11

Hydrochlorothiazide

12

Sertraline

13

Simvastatin

14

Montelukast

15

Acetaminophen/Hydrocodone

16

Pantoprazole

Atorvastatin

18

17

Furosemide

18

Fluticasone

19

Escitalopram

20

Fluoxetine

21

Rosuvastatin

22

Bupropion

23

Amoxicillin

24

Dextroamphetamine; Dextroamphetamine Saccharate; Amphetamine;
Amphetamine Aspartate

25

Trazodone

Per PDR.net, Table 2 lists the drug generic name along with the listed treatment uses of
the drug (PDR Search, n.d). It can be seen that these commonly prescribed medications are used
to treat high cholesterol, high blood pressure, type 2 diabetes, asthma, GI issues and other related
common, high-prevalence medical conditions (PDR Search, n.d). For example, it can be seen in
the first row that Atorvastatin is a treatment for hypercholesterolemia and hypertriglyceridemia
(PDR Search, n.d).
Table 2. Top 25 Most Commonly Used Medications as per ClinCal Database and Treatment
Uses
Drug Generic Name(s)

Treatment Uses

Atorvastatin

Treatment of Hypercholesterolemia, hypertriglyceridemia

Levothyroxine

Treatment of Hypothyroidism of most etiologies in adult and pediatric
patients

Lisinopril

Treatment of Hypertension, congestive heart failure, post-myocardial
infarction, diabetic nephropathy
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Metformin

Treatment of Type 2 Diabetes in adult and pediatric patients 10 years
and older; prediabetes; adjunct treatment of patients with
hyperinsulinemia secondary to polycystic ovary syndrome;

Metoprolol

Treatment of angina pectoris, hypertension, heart failure, evolving acute
myocardial infarction

Amlodipine

Treatment of Hypertension, coronary artery disease, angina

Albuterol

Relief of acute bronchospasm and episodic wheezing in patients with
asthma or exercise-induced bronchospasm; used as reliever-therapy for
COPD in adults

Omeprazole

Treatment of Dyspepsia, pyrosis (heartburn), non-erosive
gastroesophageal reflux disease (GERD), erosive esophagitis, short-term
treatment of active benign gastric ulcer, short-term treatment of active
duodenal ulcer, long-term treatment of gastric hypersecretory conditions,
also used in antimicrobial combination regimens for H. pylori
eradication; also available over the counter for heartburn

Losartan

Treatment of Hypertension, diabetic nephropathy, proteinuria, stroke
prophylaxis in hypertensive patients with left ventricular hypertrophy
(LVH)

Gabapentin

Treatment of Restless legs syndrome, postherpetic and other neuralgias,
and adjunctively for partial seizures

Hydrochlorothiazide

Treatment of Edema, hypertension

Sertraline

Indicated for depression, OCD, panic disorder, PTSD, social anxiety
disorder, and PMDD in adults; used for OCD in children 6 years and
older

Simvastatin

Treatment of hypercholesterolemia, including hyperlipidemia,
hyperlipoproteinemia, or hypertriglyceridemia, as an adjunct to dietary
control; and for reduction in cardiovascular mortality, including
myocardial infarction prophylaxis and stroke prophylaxis

Montelukast

Asthma maintenance treatment, exercise-induced bronchospasm
prophylaxis, treatment of allergic rhinitis, seasonal allergic rhinitis

Acetaminophen/Hydroc
odone

Treatment of moderate pain to moderately severe pain

Pantoprazole

Treatment of erosive esophagitis (erosive GERD), treatment of
pathological hypersecretion associated with Zollinger-Ellison syndrome
or other hypersecretory syndromes
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Furosemide

Treatment of peripheral edema or edema associated with heart failure,
chronic lung disease (CLD), or nephrotic syndrome; adjunctive
treatment of edema in patients with acute or chronic renal failure,
treatment of hypertension

Fluticasone

Treatment of pruritus and topical inflammation associated with moderate
to severe corticosteroid-responsive dermatoses, including the treatment
of alopecia areata, discoid lupus erythematosus, generalized exfoliative
dermatitis, cutaneous lichen planus, lichen simplex chronicus, lichen
striatus, nodular prurigo, pompholyx (dyshidrosis), pemphigus,
polymorphous light eruption, psoriasis, seborrheic dermatitis, severe
contact dermatitis, severe Rhus dermatitis (due to plants like poison ivy),
and xerosis

Escitalopram

Treatment of major depression, generalized anxiety disorder (GAD)

Fluoxetine

Treatment of major depression, depressive episodes associated with
bipolar I disorder, obsessive-compulsive disorder (OCD), panic disorder
with or without agoraphobia, bulimia nervosa, premenstrual dysphoric
disorder (PMDD)

Rosuvastatin

Treatment of hypercholesterolemia, including hyperlipidemia,
hyperlipoproteinemia, or hypertriglyceridemia, as an adjunct to dietary
control, reduction of elevated total cholesterol, LDL-cholesterol,
apolipoprotein B, and triglyceride concentrations, and to increase HDLcholesterol in patients with primary hypercholesterolemia, primary
prevention of cardiovascular disease including myocardial infarction
prophylaxis and stroke prophylaxis,

Bupropion

Treatment of major depression, prevention of seasonal major depressive
disorder episodes associated with seasonal affective disorder (SAD), use
as an adjunct to psychosocial interventions in the management of
tobacco cessation (smoking cessation)

Amoxicillin

Treatment of upper respiratory tract infections, treatment of tonsillitis
and/or pharyngitis (rheumatic fever prophylaxis) secondary to
Streptococcus pyogenes, treatment of sinusitis, treatment of acute otitis
media, treatment of skin and skin structure infections, severe infections
or infections caused by less susceptible organisms, treatment of lower
respiratory tract infections (LRTIs), including community-acquired
pneumonia (CAP), treatment of urinary tract infection (UTI) including
cystitis
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Dextroamphetamine;
Dextroamphetamine
Saccharate;
Amphetamine;
Amphetamine Aspartate

Treatment of attention-deficit hyperactivity disorder (ADHD), treatment
of narcolepsy

Trazodone

Treatment of major depression

Table 3 lists the drug classifications which were identified in this review and their
definitions as directly quoted from Drugs.com (Drugs.com, n.d.). Drug classifications are
identified for each medication in column 6 of the guide. In table 3, it can be seen that there are 22
drug classifications which are defined in the second column. For example, statins are HMG-CoA
reductase inhibitors. The results in the second column are directly quoted from Drugs.com
(Drugs.com, n.d.)
Table 3. Relevant Medication Classes and Purpose per Drugs.com
Drug
Classification

Definition

Statin (HMGCoA
Reductase
Inhibitor)

Statins (also called HMG-CoA reductase inhibitors) block an enzyme called
HMG-CoA reductase (3-hydroxy-3-methylglutaryl coenzyme A reductase) that is
involved in the synthesis of mevalonate, a naturally occurring substance that is
then used by the body to make sterols, including cholesterol. By inhibiting this
enzyme, cholesterol and LDL-cholesterol production is decreased.

Thyroid Agent

Thyroid drugs (thyroid hormones) are used to supplement low thyroid levels in
people with hypothyroidism.

Angiotensin
Converting
Enzyme
Inhibitor

Angiotensin-converting enzyme (ACE) inhibitors are medications that help relax
the veins and arteries to lower blood pressure. ACE inhibitors prevent an enzyme
in the body from producing angiotensin II, a substance that narrows blood vessels.
This narrowing can cause high blood pressure and forces the heart to work harder.
Angiotensin II also releases hormones that raise blood pressure.
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Biguanide
Antidiabetic

Antidiabetic agents refer to all the distinct types of medicine involved in the
treatment of diabetes. All these agents aim to reduce blood sugar levels to an
acceptable range (called achieving normoglycemia) and relieve symptoms of
diabetes such as thirst, excessive urination, and ketoacidosis (a serious
complication of diabetes that occurs when the body cannot use glucose as a fuel
source).

Antiarrhythmic,
Class II

Group II antiarrhythmics: Beta-blockers. These work by blocking sympathetic
nervous system stimulation to the heart, thereby reducing the transmission of
impulses within the heart’s conduction system.

Selective BetaBlocker (with
calcium
channel
blocker)

Beta adrenergic blocking agents prevent stimulation of the beta-adrenergic
receptors at the nerve endings of the sympathetic nervous system and therefore
decrease the activity of the heart. They block sympathetic stimulation of the heart
and reduce systolic pressure, heart rate, cardiac contractility and output, so
decrease myocardial oxygen demand and increase exercise tolerance.

cardiovascular
agent

Cardiovascular agents are medicines that are used to treat medical conditions
associated with the heart or the circulatory system (blood vessels), such as
arrhythmias, blood clots, coronary artery disease, high or low blood pressure, high
cholesterol, heart failure, and stroke

Respiratory
Short-Acting
Beta-2 Agonist
(SEBA)

Respiratory agent is a term used to describe a wide variety of medicines used to
relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis,
chronic obstructive pulmonary disease (COPD), or pneumonia

Proton Pump
Inhibitor/PPI

PPIs reduce the production of acid by the stomach. They work by irreversibly
blocking an enzyme called H+/K+ ATPase which controls acid production. This
enzyme is also known as the proton pump and is found in the parietal cells of the
stomach wall.

Angiotensin-II
Receptor
Blocker/ARB

Angiotensin receptor blockers (also called ARBs or angiotensin II inhibitors) are
medicines that dilate (widen) blood vessels and are used in the treatment of
conditions such as high blood pressure(hypertension), heart failure, or kidney
disease in people with diabetes.

Anticonvulsant

Anticonvulsants (antiepileptics or AEDs) helps to normalize the way nerve
impulses travel along the nerve cells which helps prevent or treat seizures. When
the brain is working normally the nerve cells talk to each other using controlled
electrical signals from one nerve cell to another. This tells the body to do
everything it needs or wants to do.
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Thiazide
Diuretics

Thiazide diuretics are a type of diuretic (a drug that increases urine flow). They
act directly on the kidneys and promote diuresis (urine flow) by inhibiting the
sodium/chloride cotransporter located in the distal convoluted tubule of a nephron
(the functional unit of a kidney).

Selective
Serotonin
Reuptake
Inhibitor
Antidepressant
, SSRI

SSRI stands for Selective Serotonin Reuptake Inhibitor. SSRI antidepressants are
a type of antidepressant that work by increasing levels of serotonin within the
brain.

Systemic
Leukotriene
Antagonists

Leukotriene modifiers may be used for the treatment of certain conditions that are
associated with an allergic response.

Opioid Agonist Opioid receptors are distributed in the central nervous system and the digestive
tract. Peripheral acting agonist and antagonist are not able to penetrate the blood
brain barrier so only affect the peripheral opioid receptors.
non-salicylate
analgesic

Analgesics are medicines that are used to relieve pain. They are also known as
painkillers or pain relievers. Technically, the term analgesic refers to a medication
that provides relief from pain without putting you to sleep or making you lose
consciousness.

Loop Diuretic

Diuretics are medicines that increase urine flow (cause diuresis). Loop diuretics
are a powerful type of diuretic that work by inhibiting the sodium-potassiumchloride (Na+/K+/2Cl) co-transporter in the thick ascending loop of Henle (hence
the name loop diuretic), which is in the kidneys. This reduces or abolishes
sodium, chloride, and potassium reabsorption, leading to increased loss of
sodium, chloride, and potassium into the nephron (the functional unit of a kidney)

Corticosteroid

Inhaled corticosteroids are medicines containing corticosteroids such as
beclomethasone, budesonide, ciclesonide, flunisolide, fluticasone, or mometasone
in a preparation designed to be inhaled through the mouth. Inhaled corticosteroids
act directly in the lungs to inhibit the inflammatory process that causes asthma.
Inhaled corticosteroids help to prevent asthma attacks and improve lung function.

Antismoking
Agent

Smoking cessation agents are medicines used to assist in quitting smoking.
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miscellaneous
Antidepressant

Antidepressants are drugs that treat depression and improve the symptoms. All
types of antidepressant drugs may take more than two weeks to show any
benefits, although their pharmacological effects are produced immediately.
Miscellaneous antidepressants include all antidepressants not classified
elsewhere.

PenicillinaseSensitive
Penicillin
Antibiotic

Penicillinase resistant penicillins are antibiotics, which are not inactivated by the
penicillinase enzyme. Some bacteria produce the enzyme penicillinase that
destroys the beta-lactam ring of the antibiotic, making the penicillin ineffective.
Penicillinase resistant penicillins are used to treat resistant strains of
staphylococci and other infections.

Amphetamine

Amphetamine is a central nervous system stimulant that affects chemicals in the
brain and nerves that contribute to hyperactivity and impulse control.

Table 4 includes each drug classification in this review and the drugs included which are
classified under each group. It can be seen that the amphetamine class includes:
Dextroamphetamine; Dextroamphetamine Saccharate; Amphetamine; Amphetamine Aspartate,
while the Angiotensin Converting Enzyme Inhibitor class includes Lisinopril (PDR Search, n.d).
Table 4. Top 25 Most Commonly Used Medications as per ClinCal Database - by Drug
Classification
Drug Classification

Medications

Amphetamine

Dextroamphetamine; Dextroamphetamine Saccharate; Amphetamine;
Amphetamine Aspartate

Angiotensin Converting
Enzyme Inhibitor

Lisinopril

Angiotensin-II Receptor
Blocker/ARB

Losartan

Anti-arrhythmic, Class II

Metoprolol

Anticonvulsant

Gabapentin
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Antismoking Agent

Bupropion

Biguanide Antidiabetic

Metformin

cardiovascular agent

Amlodipine

Corticosteroid

Fluticasone

Loop Diuretic

Furosemide

miscellaneous
Antidepressant

Bupropion, Trazodone

Non-salicylate analgesic

Acetaminophen/Hydrocodone

Opioid Agonist

Acetaminophen/Hydrocodone

Penicillinase-Sensitive
Penicillin Antibiotic

Amoxicillin

Proton Pump Inhibitor/PPI

Omeprazole, Pantoprazole

Respiratory Short-Acting
Beta-2 Agonist (SEBA)

Albuterol

Selective Beta-Blocker
(with calcium channel
blocker)

Metoprolol

Selective Serotonin
Reuptake Inhibitor
Antidepressant, SSRI

Sertraline, Escitalopram, Fluoxetine

Statin (HMG-CoA
Reductase Inhibitor)

Atorvastatin, Simvastatin, Rosuvastatin

Systemic Leukotriene
Antagonists

Montelukast

Thiazide Diuretics

Hydrochlorothiazide

Thyroid Agent

Levothyroxine
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Table 5 lists the drugs that have a tinnitus effect, a vestibular effect, a hearing loss effect
and an otalgia effect. It can be seen that Atorvastatin, Lisinopril, Metoprolol, Amlodipine,
Albuterol, Omeprazole, Losartan, Sertraline, Pantoprazole, Furosemide, Escitalopram,
Fluoxetine, Bupropion and Trazodone all have a tinnitus side effect.
Table 5. List of Medications with Tinnitus Side Effect, Dizziness/Vertigo Side Effect, Hearing
Loss Side Effect, and Otalgia Side Effect
Tinnitus Side Effect
Atorvastatin
Lisinopril
Metoprolol
Amlodipine
Albuterol
Omeprazole
Losartan
Sertraline
Pantoprazole
Furosemide
Escitalopram
Fluoxetine
Bupropion
Trazodone

Vertigo/Dizziness
Side Effect
Atorvastatin
Lisinopril
Metformin
Metoprolol
Amlodipine
Albuterol
Omeprazole
Losartan
Gabapentin
Hydrochlorothiazide
Sertraline
Simvastatin
Montelukast

Hearing Loss Side
Effect
Acetaminophen/Hydr
ocodone
Furosemide
Fluoxetine
Bupropion
Trazodone

Otalgia Side Effect
Fluticasone
Fluoxetine

Acetaminophen/Hydr
ocodone
Pantoprazole
Furosemide
Fluticasone
Escitalopram
Fluoxetine
Rosuvastatin
Bupropion
Amoxicillin
Dextroamphetamine;
Dextroamphetamine
Saccharate;
Amphetamine;
Amphetamine
Aspartate
Trazodone
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Table 6 lists the drugs that have each cognitive side effect. The cognitive side effects
included in this table are amnesia, confusion, memory impairment, depression, anxiety,
hallucinations, irritability, impaired cognition, psychosis, hostility, suicidal ideation and mania. It
can be seen in this table that Atorvastatin, Metoprolol, Gabapentin, Simvastatin, Escitalopram,
Rosuvastatin and Bupropion all have an amnesia side effect.
Table 6. List of Medications by Type of Cognitive Side Effect
Amnesia Side Effect

Confusion Side Effect

Memory Impairment Side
Effect

Atorvastatin
Metoprolol
Gabapentin
Simvastatin
Escitalopram
Rosuvastatin
Bupropion
Atorvastatin
Lisinopril
Metoprolol
Omeprazole
Losartan
Gabapentin
Sertraline
Simvastatin
Montelukast
Acetaminophen/Hydrocodone
Pantoprazole
Escitalopram
Fluoxetine
Rosuvastatin
Bupropion
Amoxicillin
Dextroamphetamine; Dextroamphetamine Saccharate;
Amphetamine; Amphetamine Aspartate
Trazodone
Atorvastatin
Losartan
Gabapentin
Simvastatin
Montelukast
Fluoxetine
Rosuvastatin
Bupropion
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Depression Side Effect

Atorvastatin
Lisinopril
Metoprolol
Amlodipine
Omeprazole
Losartan
Gabapentin
Sertraline
Simvastatin
Montelukast
Pantoprazole
Fluticasone
Escitalopram
Fluoxetine
Rosuvastatin
Bupropion
Dextroamphetamine; Dextroamphetamine Saccharate;
Amphetamine; Amphetamine Aspartate
Anxiety Side Effect
Levothyroxine
Metoprolol
Albuterol
Omeprazole
Losartan
Sertraline
Montelukast
Acetaminophen/Hydrocodone
Fluticasone
Escitalopram
Fluoxetine
Bupropion
Amoxicillin
Dextroamphetamine; Dextroamphetamine Saccharate;
Amphetamine; Amphetamine Aspartate
Trazodone
Amlodipine
Hallucinations Side Effect
Lisinopril
Metoprolol
Omeprazole
Acetaminophen/Hydrocodone
Pantoprazole
Irritability Side Effect
Albuterol
Montelukast
Escitalopram
Impaired Cognition Side Effect Gabapentin
Acetaminophen/Hydrocodone
Trazodone
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Psychosis Side Effect

Hostility Side Effect
Suicidal Ideation Side Effect
Mania Side Effect

Sertraline
Fluoxetine
Bupropion
Dextroamphetamine; Dextroamphetamine Saccharate;
Amphetamine; Amphetamine Aspartate
Trazodone
Montelukast
Escitalopram
Escitalopram
Bupropion
Fluoxetine
Bupropion
Dextroamphetamine; Dextroamphetamine Saccharate;
Amphetamine; Amphetamine Aspartate
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DISCUSSION
The results of this review reveal that commonly prescribed medications can have many
adverse reactions which affect the auditory system, audiological testing and treatment of
audiological conditions. It is important for audiology professionals to be aware of common
medications which are taken by patients and be able to use that information to inform patientcentered care in the clinic. The guide presented is to be of use for audiologists, audiology
students and related professionals as a desktop guide for quick and easy use in a clinical setting.
Future directions for this research may include the extension of the guide in this format to
include more common medications. In addition to this, the guide could be updated to include the
latest information in the future. Ideally, this guide could be used as the beginning of a searchable
database, which is frequently updated to include common medications and their potential to
affect audiological testing, results and treatment.
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DISSEMINATION
This chart is to be presented in fulfillment of the Doctor of Audiology capstone project at
the CUNY Graduate Center. A digital copy will be provided to all faculty and student attendees
of presentation and can henceforth be used at student clinical sites.
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